The pass rate for June’s pharmacy registration exam has plummeted to its lowest level since the General Pharmaceutical Council (GPhC) started overseeing the assessment in 2011.
Of 2,942 candidates who sat the exam last month, 72% (2,128) achieved a pass mark, the GPhC announced today (26 July).
Last year’s June registration assessment saw a 79% success rate, despite controversy around the contents of the exam.
In 2016, the June pass rate soared to a high of 95%, while the previous year had seen a low of 74%.
Related Article: Cross-sector group to tackle barriers faced by Black pharmacy students
The average pass rate was 82% between 2011 and 2019 – 10 percentage points higher than this year’s results.
June Registration Assessment results 2011-2019
*Pass rates are rounded to the nearest whole number
| Registration year |
Total # sitting |
Total # passing |
Pass rate |
| 2019 |
2942 |
2128 |
72% |
| 2018 |
2942 |
2318 |
79% |
| 2017 |
2823 |
2208 |
78% |
| 2016 |
2804 |
2672 |
95% |
| 2015 |
2811 |
2077 |
74% |
| 2014 |
2552 |
2175 |
85% |
| 2013 |
2579 |
1999 |
78% |
| 2012 |
2475 |
2342 |
95% |
| 2011 |
2357 |
2015 |
86% |
Related Article: SSP for antidepressant medication issued
‘Challenging assessment’
GPhC chief Duncan Rudkin emphasised the importance of maintaining high standards.
He said: ‘Each assessment is carefully set so that only the candidates who demonstrate the required knowledge and understanding can pass and be eligible to join the register.
'By only registering those who pass this challenging assessment, we can provide assurance to patients and the public that the pharmacists on our register can practise safely and effectively.
Related Article: Pharmacies can join cybersecurity pilot scheme
‘Congratulations to the trainees who passed this year’s summer registration assessment. I want to wish them well for their future careers and also acknowledge the hard work of tutors and education and training providers in helping trainees prepare for this important step.’
The full analysis of this year’s assessment will be discussed by the GPhC council in September, the regulator said.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.